Middle East & Africa Upstream Bioprocessing Market Forecast to 2030 - Regional analysis - by Product Type (Bioreactors/Fermenters, Cell Culture, Filters, Bags and Containers, and Others), Workflow (Media Preparation, Cell Culture, and Cell Separation), Usage Type (Single-use and Multi-use), and Mode (In-house and Outsourced)
The Middle East & Africa upstream bioprocessing market was valued at US$ 275.22 million in 2022 and is expected to reach US$ 712.66 million by 2030; it is estimated to grow at a CAGR of 12.6% from ... もっと見る
※当ページの内容はウェブ更新時の情報です。
SummaryThe Middle East & Africa upstream bioprocessing market was valued at US$ 275.22 million in 2022 and is expected to reach US$ 712.66 million by 2030; it is estimated to grow at a CAGR of 12.6% from 2022 to 2030.Increasing Investments in R&D in Biopharmaceutical Industry Bolster Middle East & Africa Upstream Bioprocessing Market Increasing investments in research and development (R&D) in the biopharmaceutical industry are likely to bring new trends into the upstream bioprocessing market in the coming years. In March 2020, Culture Biosciences announced securing the funds of US$ 15 million (13.4 million) in the Series A investment round, citing the backing of new and existing venture capital backers. According to Culture Biosciences, the money has been used to treble the capacity of bioreactors as well as to develop more cloud-based software monitoring and development tools for biomanufacturing research and development. The company states that this investment will help scientists manage their whole R&D workflow via software applications, hence supporting the digitization of biomanufacturing R&D. As R&D investments continue to surge, particularly in novel biologics, advanced therapies, and personalized medicine, there is a parallel emphasis on optimizing upstream bioprocessing technologies and methodologies. This trend is leading to the development of innovative bioreactor systems, cell culture media formulations, and process automation solutions to enhance the efficiency, scalability, and productivity of biopharmaceutical production operations. Furthermore, the focus on R&D investments favors the development of cutting-edge bioprocessing platforms that cater to the evolving landscape of biopharmaceuticals, including next-generation therapeutic modalities and biosimilars. Additionally, dedicating R&D funds for bioprocessing trends such as continuous bioprocessing and advanced analytics for process monitoring is expected to reshape the future of upstream bioprocessing, driving the adoption of state-of-the-art technologies and establishing new benchmarks for process performance, quality, and regulatory compliance. Middle East & Africa Upstream Bioprocessing Market Overview The Middle East & Africa upstream bioprocessing market is segmented into the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa. The UAE is the largest market for upstream bioprocessing. The market is driven by extensive research projects undertaken by several research institutes, and the availability of infrastructure and facilities for fundamental as well as advanced research, particularly in the UAE and Saudi Arabia. Middle East & Africa Upstream Bioprocessing Market Revenue and Forecast to 2030 (US$ Million) Middle East & Africa Upstream Bioprocessing Market Segmentation The Middle East & Africa upstream bioprocessing market is segmented based on product type, workflow, usage type, mode, and country. Based on product type, the Middle East & Africa upstream bioprocessing market is segmented into bioreactors/fermenters, cell culture, filters, bags and containers, and others. The cell culture services held the largest market share in 2022. Based on workflow, the Middle East & Africa upstream bioprocessing market is categorized into media preparation, cell culture, and cell separation. The cell separation held the largest market share in 2022. Based on usage type, the Middle East & Africa upstream bioprocessing market is bifurcated into single-use and multi-use. The single-use held a larger market share in 2022 Based on mode, the Middle East & Africa upstream bioprocessing market is bifurcated into in-house and outsourced. The outsourced held a larger market share in 2022. Based on country, the Middle East & Africa upstream bioprocessing market is segmented into South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa. South Africa dominated the Middle East & Africa upstream bioprocessing market share in 2022. Thermo Fisher Scientific Inc, Esco Micro Pte Ltd, Sartorius AG, Danaher Corp, Getinge AB, Merck KGaA, and Corning Inc are some of the leading companies operating in the Middle East & Africa upstream bioprocessing market. Table of ContentsTABLE OF CONTENTS1. Introduction 1.1 The Insight Partners Research Report Guidance 1.2 Market Segmentation 2. Executive Summary 2.1 Key Insights 3. Research Methodology 3.1 Coverage 3.2 Secondary Research 3.3 Primary Research 4. Middle East & Africa Upstream Bioprocessing Market Landscape 4.1 Overview 4.2 PEST Analysis 5. Middle East & Africa Upstream Bioprocessing Market - Key Market Dynamics 5.1 Market Drivers 5.1.1 Commercial Use of Single-Use Bioreactors 5.1.2 Outsourcing of Biopharmaceutical Manufacturing 5.1.3 Rapid Growth of Pharmaceutical and Biotechnology Industries 5.2 Market Restraints 5.2.1 Stringent Regulatory Framework 5.3 Market Opportunities 5.3.1 Technological Advancements 5.4 Future Trends 5.4.1 Increasing Investments in R&D in Biopharmaceutical Industry 5.5 Impact of Drivers and Restraints: 6. Upstream Bioprocessing Market - Middle East & Africa Analysis 7. Middle East & Africa Upstream Bioprocessing Market Analysis - by Product Type 7.1 Bioreactors/Fermenters 7.1.1 Overview 7.1.2 Bioreactors/Fermenters: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) 7.2 Cell Culture 7.2.1 Overview 7.2.2 Cell Culture: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) 7.3 Filters 7.3.1 Overview 7.3.2 Filters: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) 7.4 Bags and Containers 7.4.1 Overview 7.4.2 Bags and Containers: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) 7.5 Others 7.5.1 Overview 7.5.2 Others: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) 8. Middle East & Africa Upstream Bioprocessing Market Analysis - by Workflow 8.1 Media Preparation 8.1.1 Overview 8.1.2 Media Preparation: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) 8.2 Cell Culture 8.2.1 Overview 8.2.2 Cell Culture: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) 8.3 Cell Separation 8.3.1 Overview 8.3.2 Cell Separation: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) 9. Middle East & Africa Upstream Bioprocessing Market Analysis - by Usage Type 9.1 Single-use 9.1.1 Overview 9.1.2 Single-use: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) 9.2 Multi-use 9.2.1 Overview 9.2.2 Multi-use: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) 10. Middle East & Africa Upstream Bioprocessing Market Analysis - by Mode 10.1 In-house 10.1.1 Overview 10.1.2 In-house: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) 10.2 Outsourced 10.2.1 Overview 10.2.2 Outsourced: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) 11. Middle East & Africa Upstream Bioprocessing Market - Country Analysis 11.1 Middle East & Africa Market Overview 11.1.1 Middle East & Africa: Upstream Bioprocessing Market - Revenue and Forecast Analysis - by Country 11.1.1.1 Middle East & Africa: Upstream Bioprocessing Market - Revenue and Forecast Analysis - by Country 11.1.1.2 South Africa 11.1.1.3 South Africa: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) 11.1.1.3.1 South Africa: Upstream Bioprocessing Market Breakdown, by Product Type 11.1.1.3.2 South Africa: Upstream Bioprocessing Market Breakdown, by Workflow 11.1.1.3.3 South Africa: Upstream Bioprocessing Market Breakdown, by Usage Type 11.1.1.3.4 South Africa: Upstream Bioprocessing Market Breakdown, by Mode 11.1.1.4 Saudi Arabia 11.1.1.5 Saudi Arabia: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) 11.1.1.5.1 Saudi Arabia: Upstream Bioprocessing Market Breakdown, by Product Type 11.1.1.5.2 Saudi Arabia: Upstream Bioprocessing Market Breakdown, by Workflow 11.1.1.5.3 Saudi Arabia: Upstream Bioprocessing Market Breakdown, by Usage Type 11.1.1.5.4 Saudi Arabia: Upstream Bioprocessing Market Breakdown, by Mode 11.1.1.6 UAE 11.1.1.7 UAE: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) 11.1.1.7.1 UAE: Upstream Bioprocessing Market Breakdown, by Product Type 11.1.1.7.2 UAE: Upstream Bioprocessing Market Breakdown, by Workflow 11.1.1.7.3 UAE: Upstream Bioprocessing Market Breakdown, by Usage Type 11.1.1.7.4 UAE: Upstream Bioprocessing Market Breakdown, by Mode 11.1.1.8 Rest of Middle East & Africa 11.1.1.9 Rest of Middle East & Africa: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) 11.1.1.9.1 Rest of Middle East & Africa: Upstream Bioprocessing Market Breakdown, by Product Type 11.1.1.9.2 Rest of Middle East & Africa: Upstream Bioprocessing Market Breakdown, by Workflow 11.1.1.9.3 Rest of Middle East & Africa: Upstream Bioprocessing Market Breakdown, by Usage Type 11.1.1.9.4 Rest of Middle East & Africa: Upstream Bioprocessing Market Breakdown, by Mode 12. Industry Landscape 12.1 Overview 12.2 Growth Strategies in Upstream Bioprocessing Market 12.3 Organic Growth Strategies 12.3.1 Overview 12.4 Inorganic Growth Strategies 12.4.1 Overview 13. Company Profiles 13.1 Thermo Fisher Scientific Inc 13.1.1 Key Facts 13.1.2 Business Description 13.1.3 Products and Services 13.1.4 Financial Overview 13.1.5 SWOT Analysis 13.1.6 Key Developments 13.2 Esco Micro Pte Ltd 13.2.1 Key Facts 13.2.2 Business Description 13.2.3 Products and Services 13.2.4 Financial Overview 13.2.5 SWOT Analysis 13.2.6 Key Developments 13.3 Sartorius AG 13.3.1 Key Facts 13.3.2 Business Description 13.3.3 Products and Services 13.3.4 Financial Overview 13.3.5 SWOT Analysis 13.3.6 Key Developments 13.4 Danaher Corp 13.4.1 Key Facts 13.4.2 Business Description 13.4.3 Products and Services 13.4.4 Financial Overview 13.4.5 SWOT Analysis 13.4.6 Key Developments 13.5 Getinge AB 13.5.1 Key Facts 13.5.2 Business Description 13.5.3 Products and Services 13.5.4 Financial Overview 13.5.5 SWOT Analysis 13.5.6 Key Developments 13.6 Merck KGaA 13.6.1 Key Facts 13.6.2 Business Description 13.6.3 Products and Services 13.6.4 Financial Overview 13.6.5 SWOT Analysis 13.6.6 Key Developments 13.7 Corning Inc 13.7.1 Key Facts 13.7.2 Business Description 13.7.3 Products and Services 13.7.4 Financial Overview 13.7.5 SWOT Analysis 13.7.6 Key Developments 14. Appendix 14.1 About The Insight Partners 14.2 Glossary of Terms
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(映画・娯楽)の最新刊レポートThe Insight Partners 社の最新刊レポート
本レポートと同じKEY WORD(media)の最新刊レポート
よくあるご質問The Insight Partners社はどのような調査会社ですか?The Insight Partnersはインドに本社を置く調査会社です。経験豊富な専門家チームを通じて、お客様に最適な調査と分析を提供することに専念しています。幅広い分野をカバーしていますがヘルスケ... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/10/22 10:26 151.74 円 164.56 円 199.74 円 |